Amyloid β-peptide (42-1) (human)
Cat. No. 3391
Biological ActivityInactive control peptide for amyloid β-peptide (1-42) (Cat. No. 1428), the predominant form of amyloid β-peptide found in the brains of patients with Alzheimer's disease.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Walsh et al (2002) Amyloid-beta peotide is toxic to neurons in vivo via indirect mechanisms. Neurobiol.Dis. 10 20. PMID: 12079400.
Boyd-Kimball et al (2005) Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: Implications for Alzheimer's disease. Brain Res. 1004 206. PMID: 15885219.
Xiong et al (2007) Mitochondrial respiratory inhibition and oxidative stress elevate β-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp.Brain Res. 181 435. PMID: 17429617.
If you know of a relevant citation for this product please let us know.
Keywords: Amyloid b-peptide (42-1) (human), supplier, Inactive, control, peptide, β-Amyloid, beta-Amyloid, b-amyoid, Precursor, Protein, APP, Secretase, beta, Peptides, Amyloid, β-peptide, beta-peptide, (42-1), (human), amyloidbeta, amyloidb, amyloidβ
Find multiple products by catalog number
New Products in this Area
Potent and selective TGR5 agonistNSC 617145
Werner syndrome helicase (WRN) helicase inhibitorT2AA
PCNA inhibitorSEN 1269
Amyloid-β aggregation inhibitor
September 17, 2015